Soleil Starts Insulet (PODD) at Buy, DexCom (DXCM) at Hold
Tweet Send to a Friend
Soleil Securities initiates coverage on Insulet (Nasdaq: PODD) with a Buy rating and $14 price target.
The firm believes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm believes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
